2013 Heroes of Chemistry

Pfizer - Crizotinib

The American Chemical Society honors five scientists from Pfizer for developing Crizotinib, a revolutionary non-small cell lung cancer pharmaceutical agent. The discovery of Crizotinib is the first new small molecule drug for lung cancer approved by the Federal Drug Administration (FDA) in more than six years and represents a significant advancement in the treatment of non-small cell lung cancer.

In this video, J. Jean Cui, Pei-Pei Kung, Mason Pairish, Hong Shen and Michelle Tran-Dubé of Pfizer, were honored as Heroes of Chemistry in 2013 by the American Chemical Society for developing Crizotinib.

The Pfizer Team

Image of J. Jean Cui

J. Jean Cui, an Associate Research
Fellow in Medicinal Chemistry at
Pfizer

Image of Hong Shen

Hong Shen, a Senior Scientist
at Pfizer Global Research &
Development, La Jolla Laboratories

Image of Pei-Pei Kung

Pei-Pei Kung, a Senior Principal
Scientist in Medicinal Chemistry
at Pfizer Global Research and
Development

Image of Michelle Tran-Dubé

Michelle Tran-Dubé, a Principal
Scientist in Medicinal Chemistry
at Pfizer

Image of Mason Pairish

Mason Pairish, a Senior Scientist
in Medicinal Chemistry at Pfizer



Congratulations to the 2013 ACS Heroes from Pfizer!